MYOEPITHELIAL CARCINOMA OF SALIVARY GLAND

This adverse event was reported 2 times

These drugs are most commonly taken by patients reporting MYOEPITHELIAL CARCINOMA OF SALIVARY GLAND:

# Drug Count
0 PEMIGATINIB 1
1 SECUKINUMAB 1
See all common drugs associated with MYOEPITHELIAL CARCINOMA OF SALIVARY GLAND

MYOEPITHELIAL CARCINOMA OF SALIVARY GLAND is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEMIGATINIB 1 0.0012
1 SECUKINUMAB 1 0.0000
See all drugs enriched for association with MYOEPITHELIAL CARCINOMA OF SALIVARY GLAND

These drug classes are most commonly taken by patients reporting MYOEPITHELIAL CARCINOMA OF SALIVARY GLAND:

# Drug class Count
0 Interleukin-17A Antagonist [EPC] 1
1 Kinase Inhibitor [EPC] 1
See all common drug classes associated with MYOEPITHELIAL CARCINOMA OF SALIVARY GLAND

MYOEPITHELIAL CARCINOMA OF SALIVARY GLAND is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-17A Antagonist [EPC] 1 0.0000
1 Kinase Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with MYOEPITHELIAL CARCINOMA OF SALIVARY GLAND